PEDMORE MEDICAL PRACTICE — All Prescriptions & Medications — Page 9

Practice Code: M87030 | STOURBRIDGE, DY9 8DJ

Showing results 401-450 of 479

MedicationItems (12m) ↓QuantityCostvs National
153,000£217-60.7% ▼
151,341£108-69.7% ▼
15870£2.8K+31.7% ▲
15630£109-49.0% ▼
Bisacodyl14456£25-89.3% ▼
Valsartan with diuretic14392£189+5.7% ▲
Bezafibrate14648£157-74.0% ▼
Levocetirizine14840£107-10.2% ▼
Metoclopramide hydrochloride141,064£33-83.1% ▼
Lymecycline14812£93-88.4% ▼
Ciprofloxacin14481£75-64.9% ▼
Fesoterodine fumarate141,134£93-64.5% ▼
Ferrous gluconate141,242£35-70.7% ▼
Other multivitamin preparations14730£124-91.9% ▼
Meloxicam14420£13-78.8% ▼
Fludroxycortide1418£469+32.8% ▲
1414£2.5K-60.8% ▼
14175£205+3.1% ▲
141,790£391-45.7% ▼
Torasemide13840£354+15.8% ▲
Eprosartan13728£354-35.6% ▼
Sulpiride131,456£121-51.5% ▼
Naltrexone hydrochloride13364£939-8.4% ▼
Biphasic insulin lispro13235£1.4K-69.7% ▼
Alogliptin/metformin13728£329-68.8% ▼
Glucagon1314£162-14.5% ▼
Raloxifene hydrochloride13728£103-12.0% ▼
Powder thickener - starch based (0913161)133,645£102-9.5% ▼
Fluorometholone13105£34-9.8% ▼
Apraclonidine13936£4.2K+3.2% ▲
Budesonide1326£262-16.4% ▼
Adapalene and benzoyl peroxide13645£279-75.7% ▼
Terbinafine hydrochloride13645£118-65.0% ▼
13170£89-59.8% ▼
13520£195-11.5% ▼
1394£495+91.6% ▲
Telmisartan12784£177-79.3% ▼
Formoterol/glycopyrronium/budesonide1219£803-80.1% ▼
Amisulpride12720£197-82.9% ▼
Doxylamine succinate/pyridoxine hydrochloride12700£998+8.7% ▲
Lacosamide12672£1.6K-77.7% ▼
Dexamethasone121,115£256-61.5% ▼
Dutasteride12720£41-76.6% ▼
Dantrolene sodium122,688£432-33.5% ▼
Brinzolamide/brimonidine12120£211-65.0% ▼
Benzoyl peroxide12360£62-14.8% ▼
Other toiletry preparations125,500£74-71.9% ▼
12178£41-69.6% ▼
1213£65-76.6% ▼
121,750£107+92.6% ▲
← Back to PEDMORE MEDICAL PRACTICE
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.